 |
|
|
|
|
Cocaine Addiction Vaccine Shows Some Success
|
| | | | Related Healthscout Videos | |
|
Page: << Prev | 1 | 2 | 3 "These cocaine users were also methadone-maintained and opiate-dependent, representing a small subgroup of those addicted to cocaine," Parsons noted. "From this study, we have no idea whether or not this vaccine will be effective in those whose primary, or even sole addiction, is to cocaine."
And the participants were already in a methadone-maintenance program, giving them more incentive to stay in the trial, Prenzlauer said.
The study was sponsored by the U.S. National Institute on Drug Abuse and the Veterans Affairs Mental Illness Research, Education and Clinical Center. Martell is also a medical director at drug company Pfizer.
Text Continues Below
More information
There's more on cocaine and other substance abuse at the U.S. National Institute on Drug Abuse.
Page: << Prev | 1 | 2 | 3
|
Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 10/5/2009
|
|
SOURCES: Jeffrey T. Parsons, Ph.D., professor and chair of psychology, Hunter College, New York City;
Steven Prenzlauer, M.D., assistant professor of psychiatry and behavioral science, Texas A&M Health Science Center College of Medicine, Round Rock, and director of psychiatry and behavioral health, Lone Star Circle of Care, Round Rock, Texas; Jean Bidlack, Ph.D., professor of pharmacology and physiology, University of Rochester Medical Center, Rochester, N.Y.; Nora Volkow, M.D., director, U.S. National Institute on Drug Abuse; Thomas Kosten, M.D., professor of psychiatry and neuroscience, Baylor College of Medicine, Houston; October 2009, Archives of General Psychiatry
|
.gif)
